Recommends correcting serum potassium to the laboratory reference range and repeating aldosterone-to-renin ratio (ARR) screening when the initial screen is negative in a hypertensive patient with hypokalemia. Use when a clinician encounters a negative PA screen in a hypertensive patient with hypokalemia and wonders whether to repeat testing after potassium repletion.
Installs into .claude/skills of the current project.
Are you the author of Endo Pa Repeat Screen Hypokalemia?
Add the live security badge to your README. It updates with every re-scan.
[](https://www.skillsdirectory.com/skills/dromlakhani-endo-pa-repeat-screen-hypokalemia)
---
name: endo-pa-repeat-screen-hypokalemia
description: Recommends correcting serum potassium to the laboratory reference range and repeating aldosterone-to-renin ratio (ARR) screening when the initial screen is negative in a hypertensive patient with hypokalemia. Use when a clinician encounters a negative PA screen in a hypertensive patient with hypokalemia and wonders whether to repeat testing after potassium repletion.
---
# Repeat PA screening after correcting hypokalemia if initial screen negative
## STEP 1 — Gather Information
Collect serum potassium, plasma aldosterone, plasma renin activity (or direct renin concentration), calculate aldosterone-to-renin ratio (ARR), and review medication list for interfering agents (e.g., MRAs, ACEi, ARBs, diuretics, beta-blockers).
## STEP 2 — Rule In / Rule Out
Is serum potassium below the laboratory reference range? If yes, proceed to correct hypokalemia; if no, evaluate for other causes of false-negative PA screen (e.g., interfering medications, suboptimal sample handling).
## STEP 3 — Classify or Stratify
After correcting potassium to within the laboratory reference range, repeat PA screening (aldosterone, renin, ARR). If the repeat screen is positive (ARN >20 by immunoassay or >70 by LC-MS/MS-adjusted criteria, with suppressed renin), classify as likely PA; if negative, consider alternative explanations.
## STEP 4 — Decide
If repeat screen is positive, initiate PA-specific diagnostic workup (e.g., adrenal venous sampling consideration); if repeat screen remains negative, reassess clinical suspicion and consider repeat screening in future if hypokalemia recurs or hypertension worsens.
## Clinical Guardrails / Mimics / Pitfalls
Do not rule out PA based on a single negative screen in hypokalemia; do not repeat PA screening without first correcting potassium to normal range; do not ignore interfering medications that may suppress aldosterone or alter renin; avoid using hemolyzed samples for potassium measurement.
## Concrete Clinical Example
A 52-year-old hypertensive patient with serum K+ 2.8 mmol/L has an initial ARR of 15 (immunoassay) with suppressed renin. After KCl repletion to 4.2 mmol/L, repeat ARR is 38 with suppressed renin, prompting adrenal venous sampling.
**Source:** Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2025, DOI: 10.1210/clinem/dgaf284
> **TODO:** consider adding scripts/calc.py for the endo-pa-repeat-screen-hypokalemia calculator
